Skip to main content
. 2023 Mar 31;102(13):e33419. doi: 10.1097/MD.0000000000033419

Table 2.

The tested markers values in different groups.

Variables Control mPE sPE Control vs mPE Control vs sPE mPE vs sPE
Ca 2.18 ± 0.06 2.19 ± 0.15 2.10 ± 0.17 0.799 0.001 0.001
PLT 222.46 ± 61.22 212.48 ± 61.40 212.83 ± 76.44 0.189 0.370 0.680
Cr 45.31 ± 9.71 51.65 ± 9.54 58.69 ± 16.39 0.015 < 0.001 0.012
ALB 38.66 ± 4.78 34.46 ± 4.34 28.68 ± 3.98 < 0.001 < 0.001 < 0.001
Fib 4.02 ± 0.50 4.04 ± 0.65 4.34 ± 0.77 0.878 0.001 0.001
APTT 28.74 ± 3.80 28.52 ± 3.19 29.31 ± 5.08 0.833 0.398 0.496
PT 11.85 ± 3.49 11.04 ± 0.97 11.23 ± 1.01 0.082 0.153 0.352
D-D 1.341 (1.073–1.766) 1.252 (0.998–1.795) 1.500 (1.180–3.020) 0.611 0.002 0.006
FAR 0.11 ± 0.02 0.12 ± 0.02 0.15 ± 0.03 < 0.001 < 0.001 <0.001
WBCs 10.14 ± 5.34 9.53 ± 2.94 9.73 ± 3.00 0.417 0.567 0.690
neutrophils 7.49 ± 4.42 7.32 ± 3.05 7.35 ± 2.75 0.796 0.814 0.949
lymphocytes 1.88 ± 0.79 1.65 ± 0.54 1.81 ± 0.60 0.058 0.538 0.113

Data are presented as mean ± standard deviation (SD) when the parameters were normally distributed or median and interquartile ranges for non-normally distributed variables.

ALB = albumin, APTT = activated partial thrombin time, Ca = calcium, Cr = creatinine, D-D = D-dimer, FAR = fibrinogen to albumin ratio, Fib = fibrinogen, mPE = mild preeclampsia, PLT = platelet, PT = prothrombin time, sPE = severe preeclampsia, WBC = white blood cell.